The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kapilbhai Chandarana
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kapilbhai Hasmukhbhai Chandarana, a promoter group member of Aptus Pharma Ltd, acquired 10,000 equity shares (0.15%) on May 11, 2026. Following this acquisition, his total holding increased from 7,75,000 shares (11.30%) to 7,85,000 shares (11.44%) of the company's total paid-up capital of 68,60,000 equity shares. The mode of acquisition was not specified in the disclosure. The filing was submitted to BSE (SME platform) on May 13, 2026.
A promoter increasing their stake in the company is generally seen as a positive signal, indicating confidence in the business. However, the increase is marginal at 0.15%, and the overall promoter holding remains modest at 11.44%.